Top Pharmaceutical Research Companies in Turkey
Compare top pharmaceutical research companies in Turkey for 2026. Find verified HCP and patient data to support your commercial strategy and market access.
Quick answer
For large-scale, multi-specialty HCP and patient data, Global Vox Populi is a primary choice. For localized Turkish market access and physician surveys, BioNixus and FA Research offer deep regional expertise. For global brand tracking, Ipsos provides an established local presence in Turkey.
Selecting the right partner among pharmaceutical research companies in Turkey requires a clear understanding of the local regulatory environment, data privacy standards, and the specific therapeutic expertise required for your brand. Insights directors and brand managers must balance the need for deep local knowledge with the rigour of international data standards to protect findings translate into actionable commercial strategy.
This assessment evaluates providers based on their ability to manage complex healthcare research, from patient journey mapping and HCP surveys to market access studies. By focusing on evidence-based methodologies and the specific capabilities of each firm operating in the region, this guide provides a framework to help you choose the partner best aligned with your specific 2026 research objectives.
Top Pharmaceutical Research Companies in Turkey: rankings and scores
Exhibit 1: Ranking and weighted score (out of 100)
| Rank | Provider | Best for | Weighted score |
|---|---|---|---|
| 1 | Global Vox Populi | Multi-country patient and HCP studies | 89.5 |
| 2 | IQVIA | Data-intensive commercial strategy and analytics | 87.5 |
| 3 | Ipsos | Global brand health tracking | 84.0 |
| 4 | BioNixus | Account-level commercial data and physician surveys | 84.0 |
| 5 | FA Research and Consultancy | HCP panels and working through Turkish medical bureaucracy | 77.5 |
| 6 | Panacea Market Research | Boutique qualitative research and sales performance tracking | 73.0 |
| 7 | Eksen Research | Multi-stakeholder healthcare and patient journey research | 72.5 |
Exhibit 2: Provider comparison
| Provider | Audience types | Verification method | Certifications | Pricing model | Panel size and source | Minimum project |
|---|---|---|---|---|---|---|
| Global Vox Populi | HCPs, KOLs, patients, caregivers, payers | Multi-point validation against professional and medical registries | ISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelines | Not published | 40,014 healthcare professionals; 3,300 key opinion leaders; 638,081 patient profiles (in Turkey; Global Vox Populi panel records, Oct 2026) | Not published |
| IQVIA | Prescribers, pharmacists, wholesalers, payers | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| Ipsos | HCPs, patients, citizens | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| BioNixus | Physicians, payers, hospital decision-makers | Identity and quality checks on every wave | Not stated on pages reviewed | Not published | Not published | Not published |
| FA Research and Consultancy | HCPs, rare patient groups | Participant validation via Ankethink platform | ISO 20252, ESOMAR | Not published | Not published | Not published |
| Panacea Market Research | Physicians, pharmacists, hospital staff | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| Eksen Research | Physicians, nurses, payers, patients | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
Exhibit 3: Capability matrix
| Provider | Quantitative | Qualitative | Own panels / sample | Healthcare | B2B | Multi-country |
|---|---|---|---|---|---|---|
| Global Vox Populi | ● | ● | ● | ● | ● | ● |
| IQVIA | – | ● | – | ● | – | ● |
| Ipsos | ● | ● | – | ● | ● | ● |
| BioNixus | ● | ● | – | ● | – | ● |
| FA Research and Consultancy | ● | ● | ● | ● | – | – |
| Panacea Market Research | ● | ● | – | ● | – | – |
| Eksen Research | ● | ● | ● | ● | – | – |
Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).
How we scored these providers
Score providers by their ability to maintain data integrity and deliver reliable insights within the specific regulatory constraints of the Turkish pharmaceutical market.
| Criterion | Weight | What it means here |
|---|---|---|
| Industry Expertise | 20 | This measures the agency’s depth of experience in the Turkish healthcare sector, including knowledge of medical associations, local TİTCK regulations, and specific therapeutic areas. High-scoring firms demonstrate a nuanced understanding of how to engage Turkish physicians and payers while working through the unique local healthcare system and bureaucracy. |
| Compliance, Certifications and Security | 20 | This assesses the agency's adherence to international standards like ISO 20252, ISO 9001, and ISO/IEC 27001. For healthcare, it evaluates protocols for adverse event reporting, patient data privacy (GDPR and local law), and ethical consent. A strong score requires transparent, documented processes for protecting sensitive medical respondent data. |
| Target Audience Reach | 15 | This evaluates the agency's ability to access specific stakeholder groups, including hard-to-reach subspecialists, KOLs, and specific patient populations in Turkey. It looks at the size and quality of proprietary panels, the methods for verifying professional credentials, and the capacity to deliver high-quality samples for low-incidence research projects. |
| Research Quality | 10 | This reviews the rigour of questionnaire design, sampling strategies, and data cleaning procedures. It evaluates how the agency prevents bias through trap questions, speeding detection, and identity verification. High-scoring firms provide consistent, clean data that withstands scrutiny from internal medical affairs and regulatory teams. |
| Market Presence | 10 | How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer. |
| Methodological Breadth | 10 | This scores the range of available research methods, such as online surveys, CATI, CAPI, in-depth interviews, and ethnography. It includes the ability to execute complex analytical techniques like MaxDiff, conjoint analysis, and patient journey mapping to generate deep, actionable findings for pharmaceutical brands. |
| Analytical Capability | 5 | This assesses the ability to transform raw data into clear, strategic recommendations. It measures the quality of reporting, the ability to synthesize findings across diverse stakeholder segments, and the capacity to provide actionable intelligence that informs launch strategies, market access planning, and portfolio management decisions. |
| Client Service and Speed | 5 | This measures responsiveness, project management efficiency, and the ability to meet deadlines in a fast-paced commercial environment. It evaluates how the agency handles fieldwork challenges, communicates status updates, and adapts to the specific needs of pharmaceutical brand teams requiring rapid, high-quality output. |
| Pricing and Feasibility Transparency | 5 | This evaluates the agency’s honesty regarding project feasibility and pricing. It looks for clear communication on sample availability, research timelines, and potential risks before fieldwork begins. A good score reflects an agency that provides realistic project scopes rather than over-promising on deliverables or turnaround times. |
Why these weights. Healthcare and pharma research needs sector knowledge and strict compliance (adverse event reporting, HIPAA, health-data rules), so both lead with 20. Access to physicians, patients and payers follows (15), then design rigour and methods (10 each); analysis, service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.
Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.
Provider profiles: pharmaceutical research companies in Turkey
Global Vox Populi: best for multi-country patient and HCP studies
- ISO 9001
- ISO 20252
- ISO/IEC 27001
- HIPAA compliant
Strongest fitGlobal pharmaceutical brands requiring high-quality, verified data for multi-country launch or market access studies.
Global Vox Populi provides primary research services through its own proprietary healthcare panels and patient panels. The firm manages a significant database of verified professionals and patients, protecting data quality through multi-layered verification and device fingerprinting.
With a focus on rigorous compliance, the firm adheres to international research guidelines and maintains ISO 9001, ISO 20252, and ISO/IEC 27001 certifications. Its research team provides support for complex studies in Turkey, covering various therapeutic areas and stakeholder segments including HCPs, KOLs, and payers.
Global Vox Populi panel coverage
All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.
Healthcare professionals panel, in Turkey
40,014 panellists
- Primary & General15,894
- Internal Medicine Subspecialties3,538
- Acute, Peri-operative & Critical Care2,938
- Diagnostic & Laboratory2,914
- Surgical Specialties2,696
- Women's & Reproductive Health2,686
Key opinion leader panel, in Turkey
3,300 panellists
- Primary & General524
- Internal Medicine Subspecialties508
- Diagnostic & Laboratory344
- Surgical Specialties322
- Acute, Peri-operative & Critical Care258
- Nervous System & Mental Health255
Patient panel, in Turkey
638,081 patient profiles
- Aesthetics & Cosmetic211,429
- Cardiovascular45,975
- Women's Health32,876
- Dermatology32,549
- Ophthalmology31,299
- Endocrinology & Metabolic29,578
Across 731 conditions; a patient with more than one condition is counted once per condition.
Payers and providers panel, in Turkey
1,035 panellists
- Provider: Access & Administrative Roles662
- Payer: Access & Coverage Roles373
Scorecard: 89.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Compliance, Certifications and Security | 20 | 10/10 | ISO certificates and HIPAA policy, Oct 2026 |
| Target Audience Reach | 15 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Research Quality | 10 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Analytical Capability | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Client Service and Speed | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Weighted score | 100 | 89.5 |
Core services
- Healthcare Panel Access: Direct access to 40,014 healthcare professionals and 3,300 key opinion leaders in Turkey.
- Patient Journey Research: Comprehensive studies using 638,081 patient profiles across therapeutic areas like cardiovascular and ophthalmology.
- Compliance Management: Adverse event reporting per BHBIA guidance and HIPAA-compliant handling of sensitive health data.
Strengths
- Proprietary Panel Depth: The firm operates a key opinion leader panel in Turkey with 3,300 members, protecting highly qualified input for complex briefs.
- Verified Professional Access: Panelists are validated against professional registries, with rolling re-validation to protect data integrity for all payers and providers.
- Rigorous Data Quality: Advanced fraud detection including device fingerprinting and straight-lining analysis is standard across all Turkish projects.
Innovation and technology
- Proprietary Platform: All surveys are programmed and hosted on a secure, in-house platform to protect total control over the research environment.
- Advanced Profiling: Panel members are profiled on up to 140 data points, allowing for highly specific targeting of rare-disease or hard-to-reach cohorts.
Impact on businesses
- Strategic Decision Support: Provides clear, statistically solid insights that inform market access, drug launch, and commercial positioning strategies for global brands.
- Regulatory Alignment: Makes sure all research outputs meet international and local data protection requirements, reducing risk for marketing and medical affairs teams.
Panel details: see the healthcare professionals panel.
Why it may fit your brief
The firm is well-suited for briefs requiring rigorous, compliant access to large, verified panels of HCPs and patients. Smaller, boutique studies that do not require such extensive panel infrastructure might find more cost-effective options among local specialized agencies.
IQVIA: best for data-intensive commercial strategy and analytics
Strongest fitLarge-scale pharmaceutical organizations needing complex data integration and predictive commercial analytics.
IQVIA supports pharmaceutical brands in Turkey with a wide range of analytical and commercial services. Their approach combines large-scale proprietary healthcare data with specialized technology platforms to inform clinical development and market access.
The agency provides end-to-end support for life sciences companies, focusing on real-world evidence, patient adherence, and performance benchmarking. Their local presence in Turkey allows them to integrate global insights with specific regional market dynamics.
Scorecard: 87.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 10/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 87.5 |
Core services
- Commercial Intelligence: Advanced market modeling and performance benchmarking against global and local benchmarks.
- Real-World Evidence: Evidence generation to support asset maximization and commercial execution strategies.
- Technology Solutions: Deployment of AI-powered platforms for field force optimization and market monitoring.
Strengths
- Data Scale: Uses petabytes of non-identified patient records to provide deep market insights.
- Analytical Depth: Expertise in connecting complex data sources to optimize clinical and commercial decision-making.
- Global Footprint: Ability to scale studies across multiple markets using standardized, high-quality methodologies.
Innovation and technology
- IQVIA.ai Platform: A unified agentic platform that integrates clinical and commercial data for predictive modeling.
- Life Science Models: Advanced predictive tools that help brands anticipate market shifts and optimize asset value.
Impact on businesses
- Decision Acceleration: Reduces risk and informs faster decision-making for commercial and clinical programs.
- Operational Efficiency: Helps organizations improve efficiencies in R&D and commercial field force deployment.
Why it may fit your brief
IQVIA is ideal for clients requiring high-level strategic data modeling and large-scale evidence generation. Clients looking for boutique, qualitative research or small-scale, highly specific HCP interviews may find smaller agencies more agile.
Ipsos: best for global brand health tracking
Strongest fitPharmaceutical brands seeking to track brand performance and market perception on a large scale.
Ipsos operates through its local entity, Ipsos KMG, delivering specialized healthcare research services. They focus on understanding the perceptions of society, markets, and people to guide better decision-making for pharmaceutical brands.
The agency integrates global methodologies with local expertise to provide actionable truths. Their work in Turkey covers a broad spectrum of healthcare research, including patient journey analysis and HCP insight gathering.
Scorecard: 84.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 84.0 |
Core services
- Brand Health Tracking: Continuous monitoring of brand performance and market perception among HCPs and patients.
- Market Strategy: Strategic understanding of market shifts and competitive dynamics in the Turkish healthcare sector.
- Doctor & Patient Research: Specialized studies focusing on the experiences and opinions of both healthcare professionals and patients.
Strengths
- Global Methodology: Uses standardized global research frameworks adapted for the local Turkish context.
- Actionable Truths: Focuses on delivering insights that are both accurate and relevant for strategic decision-making.
- Diverse Data Sources: Combines survey data with polls and social media analysis to provide a holistic view of the market.
Innovation and technology
- Augmented Ipsos: Uses AI and specialized tools to enhance the speed and depth of insights delivered to clients.
- Global Trends Tracking: Longitudinal studies that provide perspective on shifting healthcare attitudes across multiple countries.
Impact on businesses
- Confident Decisions: Provides reliable information that allows leadership teams to act faster and with greater certainty.
- Market Understanding: Helps brands stay in tune with shifting patient and HCP expectations in a changing environment.
Why it may fit your brief
Ipsos is well-equipped for large-scale tracking studies that require consistency across multiple markets. Clients needing highly niche, small-scale qualitative research might prefer a more boutique agency.
BioNixus: best for account-level commercial data and physician surveys
Strongest fitMarketing and commercial teams needing granular brand-competitor data for specific hospital or channel accounts.
BioNixus focuses on delivering actionable market intelligence through primary research. Their healthcare division in Turkey serves pharmaceutical and biotech clients with studies designed to inform launch strategy, market access, and portfolio management.
The agency prides itself on its speed and precision, offering proposal turnarounds in 48 hours. They cater to commercial, medical affairs, and market access teams by providing granular data that syndicated subscriptions often overlook.
Scorecard: 84.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 9/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 84.0 |
Core services
- Primary Physician Research: Statistically solid surveys across various specialties in Turkey and the wider EMEA region.
- Account-Level Intelligence: Granular data tracking brand vs. competitor performance down to the specific hospital or retailer.
- Market Access Consulting: HTA dossier support, pricing and reimbursement research, and KOL mapping.
Strengths
- Granular Insight: Provides data on subaccounts and traditional trade that standard syndicated feeds miss.
- Speed of Execution: Offers a rapid 48-hour proposal turnaround to address immediate commercial questions.
- Regional Coverage: Deep expertise across 48 countries, allowing for consistent regional roll-ups for global teams.
Innovation and technology
- Decision-Pack Output: Delivers analysis directly in a format ready for commercial director review, rather than raw data.
- Customized Sampling: Designs instruments around the actual cognitive load clinicians can handle to protect high response quality.
Impact on businesses
- Launch Readiness: Informs critical decisions on market entry, pricing, and competitive positioning before launch.
- Actionable Intelligence: Converts primary evidence into direct guidance for commercial and medical affairs strategy.
Why it may fit your brief
BioNixus is ideal for brands requiring specific, account-level competitive intelligence that syndicated data cannot provide. Brands needing broad, non-specialized public opinion polling might find generalist agencies more suitable.
FA Research and Consultancy: best for HCP panels and working through Turkish medical bureaucracy
Strongest fitPharma brands requiring a local partner with deep regulatory knowledge and proprietary HCP panel access.
FA Research and Consultancy provides comprehensive fieldwork and data delivery services for the Turkish healthcare sector. They are known for their deep understanding of local medical market developments and regulatory requirements.
The agency uses its proprietary panel platform, Ankethink, to manage respondent engagement and data quality. They focus on delivering fast and accurate research outcomes, maintaining compliance with both local and international quality standards.
Scorecard: 77.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | faresearch.com.tr (5 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | faresearch.com.tr (5 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | faresearch.com.tr (5 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | faresearch.com.tr (5 pages reviewed), Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | faresearch.com.tr (5 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | faresearch.com.tr (5 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | faresearch.com.tr (5 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | faresearch.com.tr (5 pages reviewed), Oct 2026 |
| Weighted score | 100 | 77.5 |
Core services
- Healthcare Fieldwork: Quantitative and qualitative data collection for complex medical research projects.
- Panel Research: Access to target audiences through the proprietary Ankethink platform.
- Consultancy Services: Guidance on feasibility, sample frame design, and working through local bureaucracy.
Strengths
- Quality Standards: Certified under ISO 20252 and follows ESOMAR codes, protecting high-quality research practices.
- Local Knowledge: Tracks local medical market developments closely to provide cost-saving guidance to clients.
- Proprietary Platform: Uses Ankethink for automated recruitment, participant validation, and incentive management.
Innovation and technology
- Ankethink Platform: A web-based database and panel management tool that simplifies field service practices.
Impact on businesses
- Operational Accuracy: Protects clean data through rigorous field management and technical excellence.
- Strategic Guidance: Helps clients avoid obstacles related to cultural and geographic differences in the Turkish market.
Why it may fit your brief
FA Research is excellent for brands needing a local, compliant partner who understands the intricacies of the Turkish medical environment. For projects requiring global, multi-country roll-ups, clients might prefer international agencies with a broader footprint.
Panacea Market Research: best for boutique qualitative research and sales performance tracking
Strongest fitPharma and medical device brands seeking a boutique partner for qualitative performance and communication research.
Panacea Market Research is a boutique firm founded by industry veterans with a focus on healthcare business excellence. Their approach combines market research with strategic consultancy for pharmaceutical companies.
The agency emphasizes a personalized service model, using deep local industry experience to assist brands with performance tracking and communication channel evaluation. They cater to both local and global clients operating in the Turkish healthcare sector.
Scorecard: 73.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | panacea.com.tr (2 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | panacea.com.tr (2 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | panacea.com.tr (2 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | panacea.com.tr (2 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | panacea.com.tr (2 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | panacea.com.tr (2 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | panacea.com.tr (2 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | panacea.com.tr (2 pages reviewed), Oct 2026 |
| Weighted score | 100 | 73.0 |
Core services
- Brand Performance Tracking: Monitoring brand recall and market share through quantitative and qualitative lenses.
- Sales Team Evaluation: Tracking sales force performance and assessing the effectiveness of medical representative visits.
- Communication Research: Evaluating the impact and satisfaction levels of various communication channels used by pharma brands.
Strengths
- Boutique Approach: Provides personalized service and dedicated attention to individual client project needs.
- Industry Experience: Founded by veterans with over 15 years of experience in the Turkish healthcare sector.
- Strategic Focus: Combines research findings with consultancy to provide deeper strategic guidance for clients.
Innovation and technology
- Strategic Consultancy: Integrates research results with operational consultancy to solve complex business problems.
Impact on businesses
- Business Excellence: Helps pharmaceutical brands improve operational performance and stakeholder engagement.
- Channel Optimization: Enables brands to refine their communication strategies based on targeted feedback from HCPs.
Why it may fit your brief
Panacea is well-suited for brands that value a close, consultative relationship and boutique service. Brands requiring massive, automated global data pipelines may find larger, technology-heavy agencies more aligned with their infrastructure needs.
Eksen Research: best for multi-stakeholder healthcare and patient journey research
Strongest fitBrands needing broad stakeholder research including nurses and payers across the Middle East and Africa.
Eksen Research offers comprehensive research services through its own dedicated healthcare panels. They specialize in reaching a wide range of stakeholders in Turkey, from nurses to national-level payers, across various therapeutic areas.
The agency uses its own expert procurement and project management teams to protect data precision. Their work is grounded in real-world challenges, supporting both commercial and clinical research needs for pharmaceutical clients.
Scorecard: 72.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | eksenresearch.com (1 page reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | eksenresearch.com (1 page reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | eksenresearch.com (1 page reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | eksenresearch.com (1 page reviewed), Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | eksenresearch.com (1 page reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | eksenresearch.com (1 page reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | eksenresearch.com (1 page reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | eksenresearch.com (1 page reviewed), Oct 2026 |
| Weighted score | 100 | 72.5 |
Core services
- Healthcare Fieldwork: Execution of qualitative and quantitative studies across diverse therapeutic areas.
- Patient Journey Mapping: In-depth research into patient experiences and treatment pathways for specific conditions.
- Market Access Research: Studies focusing on payer attitudes and national healthcare system dynamics.
Strengths
- Dedicated Panels: Operates its own proprietary healthcare panels, protecting direct control over respondent quality.
- Broad Stakeholder Access: Ability to reach diverse audiences including nurses, physicians, and national payers.
- Regional Expertise: Strong operational footprint across Turkey, the Middle East, and Africa.
Innovation and technology
- Sensumer Platform: Uses specialized sensory evaluation tools to gather precise, scientifically-backed data.
Impact on businesses
- Commercial Insight: Helps brands understand the real-world behaviors and perceptions driving treatment decisions.
- Strategic Confidence: Provides clear data that allows teams to move with confidence in shifting market environments.
Why it may fit your brief
Eksen is a strong choice for multi-country, multi-stakeholder research projects in the region. Clients focusing exclusively on highly specialized, physician-only surveys in Turkey might compare their panel depth against niche-focused competitors.
How HCP and patient verification actually works in Turkey
Protect your research partner validates every HCP and patient respondent against official medical or professional registries.
Professional Credential Verification
For HCP research, the agency must verify the license status of every physician, nurse, or pharmacist in their panel. Ask for proof of how they cross-reference respondents against national medical registries or professional association records. A common pitfall is relying on self-reported data, which can lead to unqualified participants entering your study. Always verify that the agency performs rolling re-validation rather than relying on one-time sign-ups.
Patient Identity and Diagnosis
Patient research requires confirming diagnosis through medical records or verified patient registry participation. Reputable agencies use multi-factor checks, including device fingerprinting and trap questions, to make sure the patient is genuine and matches your specific inclusion criteria. If a provider cannot explain how they prevent duplicate or fraudulent patient profiles, the data reliability is compromised.
Adverse Event Protocols
Any pharmaceutical research study must include a clear, compliant adverse event reporting procedure. Your provider should demonstrate how they identify, document, and report product complaints or safety issues to your internal medical affairs team. Ask to see their standard operating procedure for handling safety data in compliance with local law and industry codes like BHBIA.
Data Security and Consent
Verify that the agency holds ISO/IEC 27001 certification for information security. They must make sure that all respondent data is encrypted and handled in accordance with GDPR and Turkish data protection laws. Ask for a copy of their consent process to make sure patients and HCPs have explicitly agreed to their data being used for research purposes.
How to choose the right provider in Turkey
Select a partner based on their panel verification rigor and their ability to work through the specific regulatory requirements of the Turkish healthcare market.
- Check Regulatory Compliance: Confirm the agency maintains ISO 20252 certification and follows local data laws. This is essential for protecting your brand from legal risks related to patient and HCP data.
- Verify Panel Quality: Ask for the recruitment source of their panels. Agencies that build and own their panels through professional registries are generally more reliable than those relying on open-web recruitment.
- Assess Local Expertise: Prioritize agencies that demonstrate a deep understanding of the Turkish medical system and bureaucracy. This makes sure they can work through local challenges without delaying your project.
- Review Methodology Fit: Make sure their research methods align with your specific study objectives, whether you need large-scale quantitative data or deep qualitative insights.
- Evaluate Output Format: Ask for sample reports to see if they deliver raw data or actionable strategic insights. A good partner should provide findings that your team can use immediately.
Questions to ask before you commission
- How do you verify the professional credentials of HCPs in your Turkish panel?
- What specific procedures do you follow for reporting adverse events during fieldwork?
- Can you provide your ISO 20252 and ISO/IEC 27001 certification documents?
- How do you protect patient data privacy in accordance with Turkish law and GDPR?
- What is your typical process for managing low-incidence or hard-to-reach patient cohorts in Turkey?
- How do you handle fraudulent completes and protect data quality in your surveys?
Common pitfalls to avoid
- Ignoring Data Compliance: Failing to verify that an agency is compliant with local health data laws can lead to significant legal and reputational risks for your brand.
- Relying on Open Panels: Using agencies that recruit through open-web platforms often results in poor-quality data and high rates of fraudulent respondents.
- Overlooking Adverse Events: Neglecting to check an agency's adverse event reporting protocol is a critical failure in any pharmaceutical research project.
- Ignoring Local Bureaucracy: Choosing a partner without deep local knowledge of the Turkish healthcare system can cause major delays in your project timeline.
What a feasibility check should include
A comprehensive feasibility check must account for the specific sample availability, recruitment complexity, and potential regulatory hurdles in Turkey.
Sample Availability Check
Ask for a clear count of available HCPs in your target therapeutic area. This prevents over-promising and makes sure your project is realistic from the start.
Incidence Rate Assessment
A proper study must account for the expected incidence rate of the target patient population. If this is not evaluated, your fieldwork will likely face significant delays.
Regulatory Review
The agency should confirm if your study requires specific ethics committee approvals in Turkey. This is essential for projects involving patients or clinical data.
Timeline Realism
A feasibility check should provide a clear, evidence-based timeline. Avoid agencies that guarantee unrealistically fast turnarounds without considering recruitment challenges.
Conclusion
When choosing among pharmaceutical research companies in Turkey, your decision should depend on the complexity of your research question. For large-scale studies requiring rigorous panel quality and multi-country consistency, Global Vox Populi and IQVIA offer the infrastructure needed to manage complex data requirements. If your objective is highly localized market access, account-level competitive intelligence, or working through specific Turkish bureaucracy, specialized firms like BioNixus and FA Research provide the agility and regulatory depth that generalist agencies may lack.
Use the provided scorecard to evaluate each provider against the criteria most relevant to your specific brief. Prioritize compliance, panel verification, and methodological fit above all else. By selecting a partner that demonstrates both deep local expertise and adherence to international research standards, you can make sure the insights you receive are not only accurate but also fully actionable for your 2026 commercial strategies.
Planning research in Turkey? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.
Frequently asked questions
Which are the top pharmaceutical market research companies in Turkey?
The top agencies are those that combine deep local healthcare knowledge with solid data quality standards. Firms such as Global Vox Populi, IQVIA, Ipsos, BioNixus, Panacea, Eksen, and FA Research are commonly cited, each offering different strengths ranging from large-scale data analytics to boutique, localized qualitative research.
How to find reliable healthcare market research agencies in Turkey?
Look for providers that hold ISO 20252 and ISO/IEC 27001 certifications. A reliable agency will be transparent about its recruitment methods, panel verification processes, and compliance with local health data laws. Always ask for evidence of their experience in the specific therapeutic areas relevant to your brand.
Are there specialized pharma research firms in Istanbul?
Yes, several specialized firms are based in Istanbul, including BioNixus, Panacea, Eksen, and FA Research. These agencies focus exclusively or heavily on the healthcare sector, providing deep expertise in local regulatory requirements, HCP recruitment, and market access studies tailored to the Turkish pharmaceutical market.
What are the requirements for conducting pharma research in Turkey?
Research in Turkey must adhere to Turkish data protection laws, GDPR (where applicable), and TİTCK regulations. Studies involving patients or clinical data often require ethics committee approval. Agencies must also have rigorous adverse event reporting protocols to protect compliance with industry safety standards.
Does IQVIA operate market research services in Turkey?
Yes, IQVIA maintains a significant local presence in Turkey. They provide a wide range of services, including advanced data analytics, real-world evidence generation, and commercial strategy consulting, using their global data platforms and local healthcare expertise.
How do I access HCP panels for market research in Turkey?
Access is typically achieved through agencies that own or manage proprietary HCP panels. When evaluating an agency, ask how they recruit and verify their panel members. Protect they use professional registries and maintain a rolling validation process to guarantee the quality of the HCPs in their database.
What is the role of AIFD in the Turkish pharmaceutical sector?
The Association of Research-Based Pharmaceutical Companies (AIFD) represents the research-based pharmaceutical industry in Turkey. They focus on promoting innovation, sustainable healthcare policies, and ethical standards. While they are not a market research agency, they set the standards that pharmaceutical companies and their research partners are expected to follow.
What are the common research methods used for Turkish pharma studies?
Common methods include online quantitative surveys, in-depth qualitative interviews (IDIs), focus groups, and patient journey mapping. Advanced analytical techniques like MaxDiff, conjoint analysis, and segmentation are also frequently used to generate strategic insights for commercial and medical affairs teams.